A new article titled IL-33 mediates lung inflammation by the IL-6-type cytokine Oncostatin M, published by MIRC’s Dr. Fernando Botelho and Dr. Carl Richards in the journal Mediators of Inflammation, investigates the relationship between IL-33 and Oncostatin M in lung inflammation. Th2 inflammatory responses in the lung underlie the development of a number of lung pathologies including those in allergic airway diseases. The group finds that IL-33, a cytokine induced in type II alveolar epithelial cells, plays a critical role in inducing a Th2 inflammatory response following Oncostatin M-induced inflammation.

Previously, the group established the role of Oncostatin M in inducing Th2 inflammatory responses and M2 macrophage accumulation as a mechanism towards lung inflammation. However, the role of IL-33 in the Th2 response in relation to Oncostatin M had yet to be elucidated. Dr. Botelho and Dr. Richards find that Oncostatin M-mediated M2 macrophage recruitment and Th2 cytokine production is entirely dependent on its upregulation of IL-33, which activated IL-5 and IL-13 production by ILC2 cells. Moreover, they find that IL-33 activates a positive inflammatory feedback loop, as it in turn induced the expression of Oncostatin M in macrophages. These findings lead to a better understanding of the critical mechanisms behind Th2-mediated pathologies and have broad implications for the development of therapies to treat inflammatory lung diseases.

Read the full article here

Accessibility for Ontarians With Disabilities Act (AODA)

 

The Faculty of Health Sciences is committed to providing a website that is accessible to the widest possible audience. If there is an accessibility issue with this website, please contact us at fhsweb@mcmaster.ca.